| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.95B | +15.3% |
| Cost of Revenue | $6.45B | +16.0% |
| Gross Profit | $1.49B | +12.2% |
| R&D Expense | $52.0M | +20.9% |
| Operating Income | $762.0M | +145.8% |
| Pre-tax Income | $668.0M | +169.4% |
| Income Tax | $166.0M | +35.0% |
| Net Income | $492.0M | +320.5% |
| EPS (Basic) | $7.43 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $236.0M | -28.0% |
| Accounts Receivable | $1.41B | +24.9% |
| Inventory | $1.60B | +36.3% |
| Current Assets | $3.31B | +22.7% |
| Total Assets | $7.56B | +8.0% |
| Current Liabilities | $1.88B | +24.5% |
| Long-term Debt | $1.94B | +11.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $152.0M | -61.2% |
| Capital Expenditures | $300.0M | +0.0% |
| Investing Cash Flow | -$320.0M | +4.5% |
| Financing Cash Flow | $103.0M | +127.6% |
| Free Cash Flow | -$148.0M | -260.9% |
| +327.0% |
| EPS (Diluted) | $7.34 | +324.3% |
| Total Liabilities |
| $4.30B |
| +13.9% |
| Stockholders' Equity | $3.15B | +1.5% |